EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics

Heng Yuan, Eun-Soo Jung iD, Soo-Wan Chae, Su-Jin Jung iD, James W Daily iD, Sunmin Park iD

Nutrients · 11.09.2024 · 16 (18) · 3061

DOI: 10.3390/nu16183061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 11.09.2024. Verfasst von Heng Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioconvergence, Hoseo University, Asan 31499, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Biomarkers, Functional Food. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disorder (MASLD) is increasingly prevalent globally, highlighting the need for preventive strategies and early interventions. This comprehensive review explores the potential of health functional foods (HFFs) to maintain healthy liver function and prevent MASLD through an integrative analysis of network pharmacology, gut microbiota, and multi-omics approaches. We first examined the biomarkers associated with MASLD, emphasizing the complex interplay of genetic, environmental, and lifestyle factors. We then applied network pharmacology to identify food components with potential beneficial effects on liver health and metabolic function, elucidating their action mechanisms. This review identifies and evaluates strategies for halting or reversing the development of steatotic liver disease in the early stages, as well as biomarkers that can evaluate the success or failure of such strategies. The crucial role of the gut microbiota and its metabolites for MASLD prevention and metabolic homeostasis is discussed. We also cover state-of-the-art omics approaches, including transcriptomics, metabolomics, and integrated multi-omics analyses, in research on preventing MASLD. These advanced technologies provide deeper insights into physiological mechanisms and potential biomarkers for HFF development. The review concludes by proposing an integrated approach for developing HFFs targeting MASLD prevention, considering the Korean regulatory framework. We outline future research directions that bridge the gap between basic science and practical applications in health functional food development. This narrative review provides a foundation for researchers and food industry professionals interested in developing HFFs to support liver health. Emphasis is placed on maintaining metabolic balance and focusing on prevention and early-stage intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBiomarkersFunctional FoodHumansNetwork PharmacologyMetabolomicsFatty LiverNon-alcoholic Fatty Liver DiseaseLiverMultiomics

Stichwörter der Autor:innen

HFFsgut microbiotametabolic dysfunction-associated steatotic liver diseaseomics approach

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Bioconvergence, Hoseo University, Asan 31499, Republic of Korea.
  • Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
  • Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
  • Research Institute of Clinical Medicine, Jeonbuk National University, Jeonju 54907, Republic of Korea.
  • Department of R&D, Daily Manufacturing Inc., Rockwell, NC 28138, USA.
  • Department of Food and Nutrition, Obesity/Diabetes Research Center, Hoseo University, 20 Hoseoro79bungil, Asan 31499, Republic of Korea.

ORCID-Profile: Eun-Soo Jung, Su-Jin Jung, James W Daily, Sunmin Park

Förderung

  • Ministry of Food and Drug Administration

Zitieren

APA

Yuan, H., Jung, E. S., Chae, S. W., Jung, S. J., Daily, J. W., & Park, S. (2024). Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics. Nutrients, 16(18), 3061. https://doi.org/10.3390/nu16183061

Vancouver

Yuan H, Jung ES, Chae SW, Jung SJ, Daily JW, Park S. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics. Nutrients. 2024;16(18):3061. doi:10.3390/nu16183061

BibTeX
@article{Yuan2024,
  author = {Yuan, Heng and Jung, Eun-Soo and Chae, Soo-Wan and Jung, Su-Jin and Daily, James W and Park, Sunmin},
  title = {Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {18},
  pages = {3061},
  doi = {10.3390/nu16183061}
}
Kostenlos starten →